Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Xylan is a complex, branched polysaccharide and a primary component of hemicellulose found in the cell walls of plants, especially hardwoods and cereal grains [1, 13]. Chemically, it consists of a backbone of beta-1,4-linked xylose units often substituted with arabinose or glucuronic acid side chains [13]. Although it is one of the most abundant biopolymers on Earth, humans lack the xylanolytic enzymes required for its digestion, meaning it reaches the large intestine intact as a dietary fiber [3, 6]. There, it is fermented by commensal gut bacteria into xylo-oligosaccharides and short-chain fatty acids (SCFAs), which provide systemic health benefits by modulating the gut-brain axis and immune signaling [2, 7]. In pharmaceutical science, xylan is not a typical molecular target like an enzyme or receptor; rather, it serves as the parent molecule for semi-synthetic drugs such as pentosan polysulfate sodium, which is indicated for interstitial cystitis and osteoarthritis [1, 3]. Additionally, xylan's resistance to upper gastrointestinal degradation makes it an ideal material for colon-specific drug delivery systems and as a regulatory inducer in synthetic biology to control the production of therapeutic proteins by engineered microbes [4, 10, 15].
Xylan functions primarily as a prebiotic substrate fermented by gut microbiota into short-chain fatty acids (SCFAs), which activate host G-protein-coupled receptors (e.g., GPR41/43) and inhibit pro-inflammatory pathways [1, 5, 9]. Sulfated xylan derivatives, such as pentosan polysulfate, act as heparinoids to inhibit proteases, hyaluronidases, and inflammatory cytokines [1, 6]. In synthetic biology, xylan acts as a chemical inducer for gene promoters in engineered probiotic bacteria, facilitating the temporal and spatial control of therapeutic protein secretion in the gut [1, 10].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xylan.